<DOC>
	<DOCNO>NCT00126789</DOCNO>
	<brief_summary>The purpose study evaluate safety matrix fentanyl patch ZR-02-01 providing relief cancer pain .</brief_summary>
	<brief_title>Fentanyl Transdermal Matrix Patch ZR-02-01 Treat Moderate Severe Cancer Pain</brief_title>
	<detailed_description>This study evaluate safety matrix fentanyl patch . The study conduct opioid-tolerant patient moderate severe cancer pain currently take around-the-clock opioid . Patients discontinue current opioid regimen begin use ZR-02-01 soon possible direction physician investigator upon entry study . Patient 's dose ZR-02-01 determine investigator use sponsor-provided conversion . Pain therapy supervision physician investigator .</detailed_description>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Patient least 18 old 75 year age time screen Patient diagnosis cancer Patient moderate severe pain related cancer treatment expect last indefinitely currently take aroundtheclock opioid treat his/her pain Patient already receive opioid therapy , demonstrate opioid tolerance A responsible adult caregiver available event emergency home Patient uncontrolled rapidly escalate pain determine investigator Patient history substance abuse substance abuse disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Pain Cancer</keyword>
	<keyword>Chronic Pain</keyword>
</DOC>